Does hypofractionated radiotherapy in breast cancer increase cardiac mortality over 20 years?

Published August 2014 | Version v1

Journal article Metadata-only

1. Universitaetsklinikum Heidelberg, Klinik fuer Radioonkologie und Strahlentherapie, Heidelberg (Germany)

no abstract available

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00066-014-0684-3

Original title (German): Erhoeht die hypofraktionierte Strahlentherapie bei Mammakarzinom die kardiale Letalitaet innerhalb von 20 Jahren?

Country of Publication: Germany
Country of Input or Organization: Germany
INIS RN: 45087911
Subject category: S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator: No Abstract
Descriptors DEI: CARCINOMAS; CRITICAL ORGANS; DELAYED RADIATION EFFECTS; EXTERNAL BEAM RADIATION THERAPY; FRACTIONATED IRRADIATION; GY RANGE 01-10; GY RANGE 10-100; HEART; ISCHEMIA; LYMPHATIC SYSTEM; MAMMARY GLANDS; NORWAY; PHOTON BEAMS; RADIATION DOSES; RADIATION HAZARDS; STATISTICS; SURVIVAL CURVES; SURVIVAL TIME
Descriptors DEC: ABSORBED DOSE RANGE; ANEMIAS; BEAMS; BIOLOGICAL EFFECTS; BIOLOGICAL RADIATION EFFECTS; BODY; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DEVELOPED COUNTRIES; DISEASES; DOSES; EUROPE; GLANDS; GY RANGE; HAZARDS; HEALTH HAZARDS; HEMIC DISEASES; IRRADIATION; MATHEMATICS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; RADIATION DOSE RANGES; RADIATION EFFECTS; RADIOLOGY; RADIOTHERAPY; SCANDINAVIA; SYMPTOMS; THERAPY; VASCULAR DISEASES; WESTERN EUROPE